COPD patients often experience shortness ... Only through thorough research will we be able to offer the best and most effective treatment to people suffering from this difficult disease," he ...

While there is no cure, an innovative treatment option is helping some patients with severe COPD or emphysema breathe easier. Endobronchial Valve Therapy (EBV) is a minimally invasive treatment ...

However, hospitalized patients might also benefit from higher doses of systemic steroids initially, followed by an oral taper dose. Conclusion. In the treatment of COPD exacerbations, systemic ...

Furthermore, many patients ... without the best treatment and care." More information: Monoclonal antibody better than standard treatment for some types of asthma attacks and COPD flare-ups ...

What do they believe to be the cause? That's true for about 85-percent of COPD cases. Gerald Staton, MD We do see occasional patients that have various industrial exposures that can seem to ...

Nearly one-third of patients treated with steroids ... world have experienced an eosinophilic asthma or COPD flare-up. Under current best treatments, 30 of them will require further care within ...

Patients with COPD who switched to LABA/LAMA/ICS vs LABA/LAMA after previously using LABA/ICS had a higher risk for severe pneumonia and death.

While millions of people live with chronic obstructive pulmonary disease (COPD), many don’t realize they have it until it ...

COPD patients with GERD, diabetes, or osteoporosis experience higher rates of exacerbations and increased healthcare ...

More information: Alan Hamilton et al, A Unified Set of Patient-Inspired Health Concepts for COPD: A North Star for Understanding Treatment Benefit, Annals of the American Thoracic Society (2024).

Therefore, the differences between treatments observed in the present study can be reasonably attributed to NAC and its dosage. In this study, patients with at least two exacerbations of COPD in ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.